Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas

Bcl-2, the gene over-expressed in follicular lymphomas (FL), is able to block chemotherapy-induced apoptosis. Consequently, we wondered whether bcl-2/IgH expression variations during treatment of FL could predict the outcome of patients with t(14;18)-bearing FL. For this purpose, we used a reverse t...

Descripción completa

Detalles Bibliográficos
Autores principales: Soubeyran, P, Hostein, I, Debled, M, Eghbali, H, Soubeyran, I, Bonichon, F, Astier-Gin, T, Hœrni, B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374283/
https://www.ncbi.nlm.nih.gov/pubmed/10555759
http://dx.doi.org/10.1038/sj.bjc.6690777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374283/
https://www.ncbi.nlm.nih.gov/pubmed/10555759
http://dx.doi.org/10.1038/sj.bjc.6690777

Ejemplares similares